Related Experiment Videos
[New pharmacological approaches of macrolides. Example of roxithromycin]
1Service de Microbiologie, CHU Bichat-Claude Bernard, Paris.
Abstract:
MACROLIDES, one of the oldest antibiotic classes, are widely used in out-patient clinics and hospitals. The major improvement in developing newer derivatives concerns pharmacokinetic properties. Increased half-lives, persisting concentrations in tissues, interstitial fluids and macrophages confer upon newer macrolides significant advantages as compared with the parent compound erythromycin. ROXITHROMYCIN, a newer macrolide has a high peak serum concentration, providing very high levels both in the interstitial fluid and intracellularly. PHARMACODYNAMIC APPROACHES are still limited with macrolides, however the very high inhibitory quotient established for tissue concentrations and interstitial fluid suggests the potential clinical efficacy of these drugs.
Insights
Newer macrolide antibiotics, like roxithromycin, offer improved pharmacokinetic properties such as longer half-lives and higher tissue concentrations. These advancements suggest potential clinical efficacy, despite limited pharmacodynamic data.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Context:
- Macrolides represent a foundational antibiotic class extensively utilized in both community and hospital settings.
- Recent advancements in macrolide development primarily focus on enhancing pharmacokinetic profiles.
Purpose:
- To evaluate the pharmacokinetic advantages of newer macrolide derivatives compared to erythromycin.
- To explore the potential clinical efficacy of macrolides based on tissue and interstitial fluid concentrations.
Summary:
- Newer macrolide antibiotics exhibit prolonged half-lives and sustained concentrations in various body compartments, including tissues, interstitial fluids, and macrophages.
- Roxithromycin, a specific newer macrolide, demonstrates high peak serum concentrations and significant intracellular and interstitial fluid penetration.
- While pharmacodynamic studies are ongoing, elevated inhibitory quotients in tissue and interstitial fluid indicate promising clinical utility for these agents.
Impact:
- Improved drug delivery and sustained therapeutic levels in target tissues.
- Potential for enhanced treatment outcomes in infections where macrolides are indicated.
- Highlights the importance of pharmacokinetic optimization in antibiotic development.